sk&f-38393 has been researched along with Cholera Infantum in 1 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zizzo, MG | 1 |
| Cavallaro, G | 1 |
| Auteri, M | 1 |
| Caldara, G | 1 |
| Amodeo, I | 1 |
| Mastropaolo, M | 1 |
| Nuzzo, D | 1 |
| Di Carlo, M | 1 |
| Fumagalli, M | 1 |
| Mosca, F | 1 |
| Mule, F | 1 |
| Serio, R | 1 |
1 other study available for sk&f-38393 and Cholera Infantum
| Article | Year |
|---|---|
Postnatal development of the dopaminergic signaling involved in the modulation of intestinal motility in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Cyclic AMP; D | 2016 |